BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22240772)

  • 21. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology.
    Furlan FC; Sanches JA
    An Bras Dermatol; 2013; 88(6):954-60. PubMed ID: 24474105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypopigmented mycosis fungoides].
    Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
    Shaikh ZI; Rahman SB
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features.
    Pileri A; Facchetti F; Rütten A; Zumiani G; Boi S; Fink-Puches R; Cerroni L
    Am J Surg Pathol; 2011 Jan; 35(1):100-9. PubMed ID: 21164293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo.
    Singh ZN; Tretiakova MS; Shea CR; Petronic-Rosic VM
    Mod Pathol; 2006 Sep; 19(9):1255-60. PubMed ID: 16778827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypopigmented mycosis fungoides associated with atopy in two children.
    Onsun N; Kural Y; Su O; Demirkesen C; Büyükbabani N
    Pediatr Dermatol; 2006; 23(5):493-6. PubMed ID: 17014650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile-onset hypopigmented mycosis fungoides mimicking vitiligo.
    Ngo JT; Trotter MJ; Haber RM
    J Cutan Med Surg; 2009; 13(4):230-3. PubMed ID: 19706233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides.
    Gerami P; Guitart J
    Am J Surg Pathol; 2007 Sep; 31(9):1430-8. PubMed ID: 17721200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
    El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
    Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early mycosis fungoides vs. inflammatory mimics: how reliable is histology?
    Inchara YK; Rajalakshmi T
    Indian J Dermatol Venereol Leprol; 2008; 74(5):462-6. PubMed ID: 19052404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of CXCR3 and CD30 in mycosis fungoides.
    Nikoo A
    Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.
    Rodney IJ; Kindred C; Angra K; Qutub ON; Villanueva AR; Halder RM
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):808-814. PubMed ID: 27515575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular mycosis fungoides: a histopathologic, immunohistochemical, and genotypic review.
    Boone SL; Guitart J; Gerami P
    G Ital Dermatol Venereol; 2008 Dec; 143(6):409-14. PubMed ID: 19169213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypopigmented mycosis fungoides: a clinical mimicker of vitiligo.
    Tolkachjov SN; Comfere NI
    J Drugs Dermatol; 2015 Feb; 14(2):193-4. PubMed ID: 25689815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8-positive granulomatous mycosis fungoides: a case report with review of the literature.
    Ishida M; Hotta M; Takikita-Suzuki M; Kojima F; Okabe H
    J Cutan Pathol; 2010 Oct; 37(10):1072-6. PubMed ID: 20579213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.